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Background: Cortical neurons display dynamic patterns of gene expression during the coincident processes of
differentiation and migration through the developing cerebrum. To identify genes selectively expressed by the
Eomes + (Tbr2) lineage of excitatory cortical neurons, GFP-expressing cells from Tg(Eomes::eGFP) Gsat embryos were
isolated to > 99% purity and profiled.
Results: We report the identification, validation and spatial grouping of genes selectively expressed within the
Eomes + cortical excitatory neuron lineage during early cortical development. In these neurons 475 genes were
expressed ≥ 3-fold, and 534 genes ≤ 3-fold, compared to the reference population of neuronal precursors. Of the
up-regulated genes, 328 were represented at the Genepaint in situ hybridization database and 317 (97%) were
validated as having spatial expression patterns consistent with the lineage of differentiating excitatory neurons. A
novel approach for quantifying in situ hybridization patterns (QISP) across the cerebral wall was developed that
allowed the hierarchical clustering of genes into putative co-regulated groups. Forty four candidate genes were
identified that show spatial expression with Intermediate Precursor Cells, 49 candidate genes show spatial
expression with Multipolar Neurons, while the remaining 224 genes achieved peak expression in the developing
cortical plate.
Conclusions: This analysis of differentiating excitatory neurons revealed the expression patterns of 37 transcription
factors, many chemotropic signaling molecules (including the Semaphorin, Netrin and Slit signaling pathways), and
unexpected evidence for non-canonical neurotransmitter signaling and changes in mechanisms of glucose
metabolism. Over half of the 317 identified genes are associated with neuronal disease making these findings a
valuable resource for studies of neurological development and disease.
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Excitatory, or projection, neurons comprise ~85% of the
neuronal population in the mature cerebral cortex.
These neurons share a stereotypical developmental tra-
jectory, with most generated in the neocortical ventricu-
lar zone (VZ) and subsequently migrating outward,
through complex and changing micro-environments, to-
wards the cortical surface. During this radial migration* Correspondence: olsone@upstate.edu
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reproduction in any medium, provided the orneurons adopt multiple morphologies and display sev-
eral distinct modes of migration [1].
The period of radial migration and early differentiation
coincides with the sequential expression of a network of
transcription factors. Core elements of the network in-
clude Pax6, Neurogenin, Neurod, Eomes (Tbr2), and
Tbr1 [2-4]. Some of the network members are known to
be essential for proper migration [5,6], axogenesis [7,8],
dendritogenesis [9], and adoption of neuronal subtype
[10-12]. The ability of neurons to simultaneously navi-
gate through the developing cortex and acquire charac-
teristic phenotypes is thus likely to depend on dynamic
patterns of gene expression during the early postmitotic
period.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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expression patterns remains incomplete. Transcriptional
profiling of microdissected samples derived from develop-
ing brain, although revealing regional and temporal differ-
ences across the brain [13-15] is limited by the inclusion
of blood vessel endothelial cells, inhibitory neurons, and
glia within the dissected tissue: the derived transcriptional
profile necessarily reflects contributions of multiple, and
often non-neuronal, cell types. These interpretive obsta-
cles can in principle be eliminated with a combined appli-
cation of cell sorting from acutely dissociated brain [16]
and subsequent transcriptional profiling [17,18].
In this study fluorescence activated cell (FAC) sorting
was used to purify neurons of the excitatory cortical
lineage, from which RNA was isolated for transcriptional
profiling. We focused on the neuronal lineage that
expresses Eomes (Tbr2), a transcription factor that is
expressed by intermediate precursor cells [19] and has
been genetically linked to microcephaly in mouse [20] and
human [21]. The target neurons were acutely dissociated
at E14.5 from a reporter transgenic mouse (Eomes::eGFP)
Gsat in which immature neurons of the excitatory lineage
express eGFP [22]. The Genepaint in situ database [23,24],
which provides comprehensive coverage of gene expres-
sion patterns in mouse embryos at E14.5 was then utilized
to validate the transcriptional profiling, from which dy-
namically expressed genes were identified. A simple but
robust technique was developed to quantify the optical
density of the in situ patterns (QISPs) across the cerebral
wall. These patterns were in turn hierarchically clustered
into putative functional groups.
Methods
Mice
All animal procedures were approved by the IACUC of
SUNY Upstate Medical University. Tg(Eomes::eGFP)Gsat
mice (The Gene Expression Nervous System Atlas Project,
NINDS Contract # N01NS02331 to The Rockefeller Uni-
versity, New York, NY) were mated to C57Bl6 (Taconic
Labs, Germantown, NY) to generate embryos. The day of
plug discovery was designated embryonic day 0.5 (E0.5).
Eomesodermin (Eomes) – also known as Tbr2 – is a tran-
scription factor of the T-box family expressed by inter-
mediate precursor cells in the excitatory neuron lineage of
the cortex [3,25]. Eomes::eGFP mice contain a BAC trans-
gene with 185 kb of 5’ and 18 kb of 3’ sequence surround-
ing the Eomes locus. In these mice selective GFP
expression is observed in developing excitatory neurons
indicating the fidelity of the large cis-regulatory elements
in the BAC transgene [26].
Tissue dissociation and cell sorting
To generate RNA from enhanced Green Fluorescent
Protein (eGFP) expressing neurons, dorsal neocorticesfrom Tg(Eomes::eGFP)Gsat embryos were rapidly dis-
sected at E13.5 and E14.5. The meninges were removed
and the cortical tissue was dissociated in 0.25% Trypsin-
EDTA solution (Invitrogen) for subsequent fluorescence
activated cell (FAC) sorting (Figure 1). Cortices from 2
embryos were used per sorted sample and 3 samples
were generated per developmental time point. Disso-
ciated cells were kept in ice-cold buffer (PBS + 2% BSA)
until FAC sorting, with the total elapsed time between
dissection and sorting < 1 hr. Cell suspensions were
sorted into GFP + and GFP- populations on a Becton
Dickinson FACS Vantage Flow Cytometer Cell Sorter
(SUNY Upstate Medical Flow Cytometry Unit). Sorting
continued until a minimum of 100,000 GFP + cells were
generated per sample. The total time required for sort-
ing the 3 samples was less than 30 min. Cells were
sorted directly into collection tubes containing RNALa-
ter™(Qiagen Inc., Valencia, CA) to minimize post-sort
RNA degradation.
RNA isolation and quality assessment
High quality total RNA was isolated using the RNAeasy™
(Qiagen) kit and flash frozen. From a total volume of
35 μl, 1 μl of the RNAeasy fluid was run on an Agilent
2100 Bioanalyzer using the RNA PicoChip to assess RNA
structural quality and quantity. Peak areas for 28 S and
18 S rRNA were determined. Degraded samples have
reduced 28 S/18 S ratios and contain additional small
RNA fragments that appear as smears in the gel photo
and small humps in the electropherogram making them
easily detectable. Samples were discarded if the total RNA
profile displayed evidence of significant degradation, as
indicated by a ribosomal RNA peak ratio (28 S/18 S)
below 1.0 (Applied Biosystems/Ambion TechNote 11:2).
No samples were lost due to RNA degradation pro-
vided the acutely dissociated cells were sorted into
collection tubes that contained RNALater™. The typ-
ical yield of total RNA was ~700 ng per 100,000 cells.
Approximately 100 ng of total RNA was used for
transcriptional profiling.
Transcriptional profiling and quality assessment
The Affymetrix Gene 1.0 ST Array (Affymetrix, Santa
Clara, CA) provides whole-transcript coverage of 28,853
mouse genes. Each gene is represented on the array by
27 probes that interrogate the full length of the gene, ra-
ther than 3’-biased interrogations used in prior tech-
nologies (e.g., the Murine U74v2 set). Purification of
RNA, probe generation, chip hybridization and array
scanning was performed at the SUNY Microarray Core
facility. Amplified and terminal-labeled cDNA were gen-
erated by the WT Sense Target Labeling Protocol (Affy-
metrix). cDNA was hybridized to the array with the
Affymetrix Fluidics Station 450, and scanned with the
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Figure 1 Isolation, profiling, and QISP analysis of GFP + (Eomes+) cortical neurons. a, Neocortex (NCX) containing GFP + neurons is
dissected, and cells isolated with flourescence activated cell sorting (FACS). Following transcriptional profiling, genes are sorted by RMA and their
level of fold up- or down-regulation compared to the FACS GFP- population. Verification of up-regulated genes is accomplished with quantified
in situ hybridization (QISP), and the verified genes hierarchically clustered (see Methods). b, Fluorescence microscopic images of a section from an
E14.5 Eomes::eGFP brain, displaying GFP + (green) and GFP- cells, that are blue due to Hoechst nuclear labeling. Subregions of Interest (sROIs)
1-20 are superimposed in white on the image. Scale bar, 25 μm. MZ, marginal zone; CP, cortical plate; IZ, intermediate zone; SVZ, subventricular
zone; VZ, ventricular zone; LGE, lateral ganglionic eminence. c, Representative outcome of FAC sort of GFP + and GFP- cells. A GFP + (P3) and
GFP- (P4) were isolated based on fluorescence (GFP-A) and side scatter (SSC-A). The boxes denote the relevant sorted populations. All in situ
hybridizations were obtained from Genepaint.
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used to determine the quality of the hybridization. A
3’/5’ probe signal ratio significantly greater or less than 1
was interpreted as indicating RNA degradation, in
which case the experiment was repeated.Quantified in situ patterns (QISPs) and network analysis
QISPs were generated by measuring the optical density
of in situ images derived from Genepaint.org, a public
database of in situ hybridizations performed on E14.5
mouse embryos [23]. The sampled regions of interest
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(MZ) to the VZ. A single ROI was first placed in rostral
cortex from an in situ section that included olfactory
bulb as an orienting landmark. This original ROI was
then subdivided into 20 sub-regions (sROI1-20), each
sub-region corresponding to 5% of the cortical wall, and
the optical density of each sROI was measured. The
measured sROI optical density was corrected by sub-
tracting background optical density, and each sROI was
then averaged with adjacent sROIs to smooth the QISP
profile (Figure 1).
Hierarchical clustering of QISPS using Pearson’s
correlation
The 20 optical density measurements corresponding to
each QISP (sROI1-20) were imported into Multiple Ex-
periment Viewer [27,28] and normalized for grouping.
Multiple Experiment Viewer can cluster data by Euclidean
distance or Pearson’s correlation. Pearson’s correlation
quantifies the covariance between samples producing
values from -1 to 1. As such it is well suited to quan-
tify the relationship between two QISPs. Importantly
two QISP with identical profiles across sROIs1-20 but
different magnitudes will have a correlation value of 1
and be tightly clustered, thereby facilitating the analysis of
co-regulated genes independent of the absolute expression
levels of each.
IPA analysis of gene groups
The IPA network analysis tool (Ingenuity Systems,
Redwood City, CA) was used to analyze clustered genes.
IPA is a literature-based analysis tool that uses relation-
ships derived from reviewed journal articles as well as
additional sources (e.g, KEGG, Gene Ontology) to gener-
ate networks of interactions within a data set. Clustered
genes were imported and network relationships were
ascertained using the “Direct and Indirect interactions”
and included “Endogeneous Chemicals” (e.g., retinoic
acid).
Results
General analysis of the E14.5 excitatory neuron
transcriptome
Previous work from our lab indicated that although
Eomes (Tbr2) protein is transiently expressed in the sub-
ventricular zone (SVZ), GFP from the transgene endures
in post-mitotic neurons for several days after the downre-
gulation of endogenous Eomes [22]. Thus the GFP +
neuron population in this system includes not only IPCs
from the SVZ, but also migrating and differentiating exci-
tatory cortical neurons. FAC sorting purified this GFP +
population to near homogeneity; analytic re-sorting of
FAC sorted GFP + cells indicated a purity of > 99%. mRNA
was successfully isolated from both the GFP + and GFP-cell populations, processed and profiled on the Affymetrix
Gene 1.0 ST Array (Figure 1). To further improve the ana-
lytic stringency we restricted analysis to genes with an ex-
pression level of RMA (robust multichip average) ≥ 7 in
the GFP + population. This threshold was based on an in-
ternal standard; for 10 eye-specific genes ([29]; Additional
file 1) we calculated from the GFP + population a RMA
value of 5.5 ± 0.7 (mean ± SD). All analyzed genes in this
report are thus expressed at a minimum of 2.8 fold over
this empirically-defined “not expressed” RMA level.
The total transcriptome of the E14.5 GFP + and E13.5
GFP + population was examined. We identified tran-
script that showed ≥ 3-fold difference (up or down) be-
tween E14.5 GFP + and E13.5 GFP + (Figure 2). The
gene expression was similar at the two time points: we
found 9 up-regulated and 35 down-regulated transcripts
(Figure 2a, 2a’ and Additional file 2 and Additional file
3). We chose to focus our further analysis on the E14.5
GFP + data, as this is the same developmental time point
used by the Genepaint mouse in situ database (www.
genepaint.org). For the E14.5 excitatory neurons more
than 13,000 unique mRNAs, out of ~25,000 represented
by the 1.0 ST Array, were above the defined threshold
(RMA = 7.0). Although numerous (i.e., 53% of all unique
mRNAs are expressed above threshold) it is similar to
recent, independent estimates of cortical neuron tran-
scriptome size (66%, [30]; 60-70%, [31]). The difference
between estimates may arise from distinct threshold
assignments as well as differences in sampling technique;
that is, purified FAC sorted embryonic neurons versus
dissections of postnatal cortical tissue.
In an effort to focus analysis upon genes most robustly
expressed by the E14.5 GFP + excitatory neuron popula-
tion, we identified 475 transcripts up-regulated ≥ 3-fold
compared to the E13.5 GFP- reference sample
(Figure 2b and 2b’ and Additional file 4). An additional
534 genes were identified as being down-regulated
by ≥ 3-fold (Additional file 5). To validate the up-
regulated genes, Genepaint.org, a public database of in
situ hybridizations performed on E14.5 mouse embryos,
was queried [23]. Of the original 475 up-regulated tran-
scripts, 352 were represented in the Genepaint in situ
database. Fort two of the up regulated transcripts not
represented by Genepaint in situs encoded small nu-
cleolar RNAs, 6 encoded RIKEN cDNA clones, 5
encoded predicted genes while the remainder of non-
represented genes were not readily grouped and pre-
sumably reflected Genepaint program priorities.
Twenty-four of the 352 (6.8%) in situ patterns either
displayed no signal in the cerebral cortex or were
represented by a single in situ section with incom-
plete sampling of the cortical wall. The remaining
328 in situ patterns were then processed for add-
itional validation and grouping.
Figure 2 Comparison of RMA values between samples. a, a’, Comparison of RMA values between E14.5 GFP + and E13.5 GFP + cells. b, b’)
Comparison of RMA values between E14.5 GFP + and E13.5 GFP- cells.
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A method to quantify the optical density of the in situ pat-
terns (QISPs) across the cerebral wall was developed (see
Methods). The method of QISP generation is potentially
subject to error due to variability of ROI positioning and
histological heterogeneity between cortical areas and sec-
tions. To assess the precision of the QISP method, mul-
tiple measurements along the rostral caudal axis were
performed using a set of E14.5 in situ hybridizations for
Dab1 (Additional file 6), which at E14.5 is strongly
expressed in the VZ and cortical plate (CP) [32], providing
two distinct regions of peak signal. The Dab1 in situ pro-
file was measured across the cerebral wall at 5 different
points within the rostral cortex on a single in situ image
(Additional file 6a). The Pearson’s correlation of these five
distinct quantifications ranged from 0.94 to 0.99 with an
average value of 0.97 (n = 5). This indicates that values
obtained with the ROI approach were consistent and
largely insensitive to the precise position of the ROI. Simi-
larly, we compared the Pearson’s correlation of Dab1 sig-
nal from three different, sagittal in situ images derived
from sections of rostral cortex along the lateral-to-medial
axis (Additional file 6b). These correlations ranged from
0.87 to 0.97 with an average correlation of 0.93 (n = 4).
Importantly, for both the rostral-caudal and lateral-medial
planes the peak signals within the VZ and CP were always
restricted to within 10% of the cerebral wall (i.e., ± 2
sROI). These tests validated the QISP analysis by indicat-
ing robust concordance of optical density measurements
between ROIs from different positions in the rostral cor-
tex and along the lateral-to- medial axis.To objectively evaluate genes of interest we quantified
the in situ pattern for Eomes itself, reasoning that up-
regulated genes would display a QISP equivalent to, or
localized more superficially than, the QISP derived for
Eomes (Tbr2). This assumption is based on the accepted
observation that, at this developmental stage, the most
mature neurons are located more superficially in the
cortex than immature neurons [33]. Eomes displayed lit-
tle expression in ventricular sROIs1-2 and higher expres-
sion in the more superficial sROIs3-11. We therefore
compared the average in situ expression in sROIs1-2 ver-
sus the average expression in sROIs3-20. Transcripts
where this ratio exceeded 1.0 (i.e., where expression was
strongest in the deep VZ) were considered invalid. This
procedure identified 11 invalid genes which were then
removed from the initial, post-Genepaint list of 328
genes. Thus 97% (n = 317) of the ≥ 3-fold up-regulated,
RMA ≥ 7 transcripts displayed a Genepaint-derived in
situ hybridization pattern that was spatially consistent
with the Eomes + excitatory neuron lineage.
Analytic grouping of the E14.5 excitatory neuron
transcriptome
To explore in greater detail groups of spatially co-
expressed genes, the 317 QISP-validated genes were
imported into the Multiple Experiment Viewer [27,28],
the signal (expression) values normalized by gene, and
then hierarchically clustered. This procedure groups to-
gether similar QISPs, and can reveal groups of genes
that are spatially co-expressed and thus potentially co-
regulated [34].
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tinct spatial distributions of dynamically regulated genes
in the radial dimension of the developing cerebral cortex
(Figure 3). Approximately 70% of up-regulated QISPs
within the Eomes + lineage display peak expression in
the CP and upper intermediate zone (IZ). The majority
of these QISPs displayed similar (i.e., tightly clustered)
expression patterns, characterized by gradually increas-
ing expression in the IZ and peak expression in the CP.
The most heterogeneous expression patterns were
observed in those QISPs with peak expression in the VZ
and IZ, with a number of QISPs displaying dual expres-
sion peaks (e.g., Gdap1, Bcl6) or expression restricted to
either the IZ or VZ (e.g., Neurod1 or Sstr2).
Four groups of genes – that is, four groups of clus-
tered QISPs – were examined using a network analysis
tool (IPA, Ingenuity Systems). The four groups were: (1)
all 317 genes; (2) 44 “deep group” genes that achieve
highest in situ expression in the VZ; (3) 49 “middle
group” genes that achieve highest expression in the IZ
and lower CP; and (4) 224 “superficial group” genes with
greatest expression in the CP. This approach was
adopted because neurons in the deep, middle, and super-
ficial regions of the cortex have distinct morphologies
and modes of migration [1] and thus can be expected to
manifest dynamic regulation of genes related to morph-
ology, navigation and migration.
Network analysis of all up-regulated genes
Network analysis of all 317 genes revealed 164 asso-
ciated with neurological disease and 85 associated with
psychological disorders; i.e., ≥ 52% of the genes have
previously been implicated in human health (Table 1).
One hundred thirteen of the genes were categorized as
Nervous System Development and Function, indicating
a substantial number (36%) of genes in this group having
been previously identified and functionally characterized.
The top “Molecular and Cellular Functions” (using the
IPA terminology) include Cell to Cell Signaling and
Interactions, Cellular Assembly and Organization, and
Cellular Movement, with the top “Canonical Pathways”
being Axonal Guidance Signaling and CDK5 signaling.
Both of these signaling pathways are known to be active
during cortical neuron migration and differentiation
[35-37]. This network analysis showed that the
entire ≥ 3-fold up-regulated gene category contains a
large number of annotated genes associated with
neuronal development, migration, differentiation, and
neurological disease.
The “deep group” of 44 up-regulated genes (14% of
the total), which is spatially co-expressed with Eomes
(2.2 fold up), achieved highest expression in the VZ
(sROIs 1-10). This group includes clusters 1, 5, 7, 8 and
11-15 (Figure 3). Along with Eomes, the deep group ischaracterized by the expression of the transcriptional
regulators Neurod4, Bcl6, Tanc2 and Myt1. Earlier stud-
ies focusing upon this deep area of cortex revealed (a)
neurons with a long leading process that translocate out
of the VZ [19,38,39] and (b) compact intermediate pre-
cursor cells in the SVZ [40]. Thus, at this point in devel-
opment the GFP + cells in the VZ and SVZ are predicted
to represent a mixture of intermediate precursors and
postmitotic neurons [41]. Consistent with this predic-
tion, IPA analysis identified DNA Replication, Recom-
bination and Repair as a functional category for these
group (p = 1.37E-04; Table 1, Additional file 7). Surpris-
ingly, Carbohydrate Metabolism was also identified (p =
3.00E-05): the deep group includes genes involved in the
synthesis (C1ql3 and Lpl) as well as level regulation
(Chga, Gipr, Pcsk2 and Sstr2) of D-glucose. The top
“Canonical Pathways” include Protein Kinase A Signa-
ling and Cardiac β-Adrenergic Signaling. Additionally, a
number of genes involved in intracellular calcium signa-
ling (Ryr3, Camk2b, Cacna1h) showed elevated expres-
sion in this group. Network analysis of deep group genes
thus suggests that the phenotypic transition from radial
glial precursor to intermediate precursor/immature cor-
tical neuron coincides with significant changes in
mechanisms of glucose metabolism and second messen-
ger signaling.
The “middle group” comprises 49 genes, or 16% of
the ≥ 3 fold up data set. The middle group QISPs, com-
prising clusters 9 and 10, are maximal in the IZ, where
developing excitatory neurons display a multipolar
morphology. Multipolar neurons (MPNs) possess mul-
tiple fine processes that lack definitive orientation, and
migrate relatively slowly in the radial direction [1]. The
top “Molecular and Cellular Functions” in this group are
Cellular Development and Cell Morphology (Table 1,
Additional file 7). The middle group is dominated by the
basic helix loop helix (bHLH) transcription regulators
Neurod6 (71.5 fold), Neurod1 (30.9 fold), Nhlh1 (11.6
fold) and Neurod2 (7.3 fold), which represent some of
the most highly up-regulated genes in the entire data
set. These bHLH transcription factors have well-
described functions in excitatory cortical neuron differ-
entiation and development [6,42]. The top “Canonical
Pathways” include Axonal Guidance Signaling and
Semaphorin Signaling in Neurons, as well as Inositol
Phosphate Metabolism. Of particular interest within the
middle group genes is cluster 9, consisting of 26 genes
that includes seven with known chemotropic signaling
functions in axon guidance. The expression of this set of
axonal guidance genes could promote the generation
and extension of axons that are observed to trail the mi-
grating cortical neuron in the upper IZ and CP [39,43].
In addition to the highly up-regulated transcription fac-
tors, the top up-regulated genes include Vglut1/Slc17A6
Figure 3 (See legend on next page.)
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Figure 3 Identification and hierarchical clustering of QISPs. a, Hierarchical clustering of 317 QISPs representing transcripts expressed≥ 3 fold
higher in Eomes + (GFP+) neurons, compared to GFP- cells. From left to right: gene clusters denoted numerically (1-15); expression levels in the
MZ + CP, IZ, and VZ (red indicates high expression, green indicates low expression) and gene number (1-317). b, Gene lists of the clustered QISPs
from panel a. QISPs were imported into Multiple Experiment Viewer (MeV) and clustered using Pearson’s correlation (see Methods). White and
shaded areas demarcate the different gene clusters.
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tory cortical neurons [44]. Network analysis of “middle
group” genes thus indicated that developing excitatory
neurons in the IZ are molecularly defined by a high ex-
pression of canonical bHLH neuronal transcription fac-
tors and axonal guidance molecules, particularly those of
the Semaphorin signaling pathway.
The “upper group” of genes (n = 224) were observed in
clusters 2, 3, 4 and 6. These genes, comprising 71% of
the up-regulated gene population, achieved highest ex-
pression in the developing cortical plate (CP), an area
that contains migrating neurons with an elongated or bi-
polar shape, and post-migratory differentiating neurons.
Within the upper group the most prominent transcrip-
tional regulators were Tbr1 (43.1 fold) [45], Bhlhb5 (19
fold) [46], and Hivep2/Schnurri2 (18 fold). Additional
transcription factors in the upper group included Prdm8
[47], Satb2 [48], Sox5 [11], and Bcl11b/Ctip2 [49]. All of
these transcriptions factors, with the exception of
Schnurri2, have demonstrated roles in corticogenesis.
Schnurri2 is, however, a BMP signaling effector, with a
neuronal function suggested by the observations that
mice deficient in Schnurri2 are hyperactive and exhibit
hypersensitivity to stress [50].
Neurons within the forming CP migrate along radial
glia fibers, from which they later detach and extend den-
drites. It is therefore not surprising that the top “Mo-
lecular and Cellular Functions” in the upper group are
Cell-To-Cell Signaling and Interaction, Cellular Assem-
bly and Organization, and Cellular Movement (Table 1,
Additional file 7). The top “Canonical Pathways” include
Corticotropin Releasing Hormone Signaling and CDK5
Signaling. A role for CDK5 signaling mechanisms is
established for many neurodevelopmental functions, in-
cluding the migration of cortical neurons along radial
glial fibers and subsequent cortical layer formation and
dendritogenesis [51,52]. In contrast the role(s) of
Corticotropin Releasing Hormone Signaling in these
neurons is less clear. The eight genes from the ≥ 3 fold
up-regulated category that populate the Corticotropin
Releasing Hormone Signaling category include four with
known functions in brain development, including the
cannabinoid receptor Cnr1 [53], the transcription factor
Mef2C [54], and nitric oxide synthase Nos1 [55]. The
remaining genes in this group include the protein
kinases Prkar1β, Prkcε and Prkcζ Network analysis of“upper group” genes thus suggest maturing excitatory
neurons in the developing CP express a number of regu-
latory and signaling factors, including the transcription
factors Tbr1, Bhlhb5, Hivep2/Schnurri2, Prdm8, Satb2,
Sox5, and Bcl11b/Ctip2.
Analysis of highly up- and down-regulated transcription
factors
To explore the spatial relationships of key transcription
factors (TFs) in the cortical lineage, we identified all ≥ 3
fold up- and down-regulated genes associated with the
Gene Ontology descriptor “transcription, nuclear” and
clustered their respective QISPs (Figure 4). These tran-
scription/nuclear QISPs span the cerebral wall at E14.5,
with subsets of QISPs showing peak expression in the
VZ, IZ and CP (Figure 4a). We were initially surprised
that Eomes itself was upregulated only 2.2 fold, a value
below our threshold for analysis. There are several rea-
sons for this low fold up value. The first is that GFP-
cells express Eomes mRNA (RMA = 10.7). The presence
of Eomes mRNA in the absence of GFP protein could
imply post-transcriptional regulation of the 5’ UTR of
the Eomes message that is included in the Eomes: :eGFP
transgene [26]. Similarly, the presence of Eomes mRNA
in GFP- cells might reflect the rapid up regulation of
Eomes mRNA in a subpopulation of cells that has yet to
express sufficient GFP protein for FAC detection and
sorting into the GFP + group. Finally, Eomes mRNA is
sharply down regulated as neurons leave the SVZ [3],
while GFP protein expression persists and is expressed
in all cortical zones superficial to the SVZ, at this devel-
opmental time point. Thus the GFP + cell population is
likely larger than the Eomes mRNA + cell population, ef-
fectively reducing the average Eomes mRNA expression
level in the GFP + population. Thus post-transcriptional
regulation and/or the difference between sharp Eomes
mRNA regulation and the delayed and extended GFP
protein expression may account for this relatively low
fold up level for this critical TF.
We first compared these genes to an earlier study of
bHLH-family TFs denoted as the “Dorsal Telencephalon
Network” [4]. Comparison to this independent data set of
13 TFs revealed 7 (54%) to be members of our ≥ 3 fold up-
regulated category: Neurod1 (31 fold), Neurod2 (7.3 fold),
Neurod6 (72 fold), Tbr1 (43 fold), Id2 (4.1 fold), Nhlh1
(12 fold) and Satb2 (12 fold) (Figure 4b). Other dorsal
Table 1 Summary of IPA Ingenuity analysis for the upper, middle, and deep cortical zones
IPA Ingenuity Pathway Analysis317 GENES (ALL)
Diseases and Disorders p-value #genes
Neurological Disease 2.40E-21 - 1.99E-02 164
Psychological Disorder 3.15E-16 - 1.99E-02 85
Genetic Disorder 7.48E-16 - 1.99E-02 213
Skeletal and Muscular Disorders 3.73E-15 - 1.99E-02 123
Gastrointestinal Disorder 8.25E-15 - 1.99E-02 133
Molecular and Cellular Signaling p-value #genes
Cell-To-Cell Signaling and Interaction 7.26E-20 - 1.99E-02 68
Cellular Assembly and Organization 5.56E-16 - 1.99E-02 82
Cellular Movement 1.28E-12 - 1.99E-02 44
Molecular Transport 2.71E-07 - 1.99E-02 67
Small Molecule Biochemistry 2.71E-07 - 1.99E-02 54
Canonical Pathways p-value Ratio
Axonal Guidance Signaling 1.26E-06 23/433
CDK5 Signaling 3.87E-05 9/94
Cardiac b-adrenergic Signaling 4.55E-05 11/154
Corticotropin Releasing Hormone Signaling 2.09E-04 9/136
Dopamine Receptor Signaling 6.05E-04 7/95
224 UPPER GENES
Molecular and Cellular Signaling p-value #genes
Cell-To-Cell Signaling and Interaction 4.31E-17 - 2.12E-02 51
Cellular Assembly and Organization 3.34E-11 - 2.12E-02 60
Cellular Movement 5.21E-10 - 1.42E-02 35
Cellular Function and Maintenance 4.02E-08 - 2.20E-02 49
Molecular Transport 4.02E-08 - 1.75E-02 49
Canonical Pathways p-value Ratio
Corticotropin Releasing Hormone Signaling 1.16E-04 8/136
CDK5 Signaling 1.76E-04 7/94
Synaptic Long Term Depression 1.62E-03 7/147
Cardiac b-adrenergic Signaling 2.35E-03 7/154
Axonal Guidance Signaling 2.65E-03 13/433
49 MID GENES
Molecular and Cellular Signaling p-value #genes
Cellular Development 9.09E-07 - 4.47E-02 12
Cell Morphology 3.82E-06 - 3.88E-02 16
Cellular Assembly and Organization 1.16E-05 - 4.18E-02 16
Cellular Movement 4.59E-05 - 4.76E-02 9
Cell-To-Cell Signaling and Interaction 4.00E-04 - 4.76E-02 13
Canonical Pathways p-value Ratio
Axonal Guidance Signaling 1.28E-07 10/433
Semaphorin Signaling in Neurons 1.54E-05 4/52
Inositol Phosphate Metabolism 7.95E-03 3/180
CXCR4 Signaling 9.66E-03 3/169
Regulation of Actin-based Motility by Rho 2.29E-02 2/91
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Table 1 Summary of IPA Ingenuity analysis for the upper, middle, and deep cortical zones (Continued)
44 DEEP GENES
Molecular and Cellular Signaling p-value #genes
Carbohydrate Metabolism 3.00E-05 - 3.88E-02 7
Molecular Transport 3.00E-05 - 3.88E-02 11
Small Molecule Biochemistry 3.00E-05 - 4.34E-02 12
DNA Replication, Recombination and Repair 1.37E-04 - 1.81E-02 2
Nucleic Acid Metabolism 1.37E-04 - 2.32E-02 7
Canonical Pathways p-value Ratio
Protein Kinase A Signaling 8.73E-05 6/328
Cardiac b-adrenergic Signaling 3.18E-04 4/154
G-Protein Coupled Receptor Signaling 1.43E-03 6/530
cAMP-mediated signaling 1.94E-03 4/219
Synaptic Long Term Potentiation 2.08E-03 3/114
In each panel the most salient “Molecular and Cellular Signaling” and “Canonical Pathways” categories are indicated, along with the associated p values. a, “all”.
b, “upper group.” c, “middle group.” d, “deep group.”.
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egory include the early genes Pax6 (7.6 fold down-regu-
lated), Neurog 1 (1.3 fold down-regulated), Neurog 2 (1.1
fold down-regulated) and Eomes itself (2.2 fold up-regu-
lated). Although Pax6 expression in the GFP + population
was below threshold (RMA= 6.2) Neurog1, Neurog2, and
Eomes were not (RMA values of 7.6, 10.1, and 11.9, re-
spectively). This suggests that the GFP + neurons in our
study substantially down-regulate Pax6 relative to neuronal
precursors, but do express the neuronal specifying TFs
Neurog1, Neurog2 and Eomes. Additionally, two genes
specific to cortical layer V-VI, Etv1 and Otx1 [56], were
down-regulated in our data (5 fold and 2 fold, respec-
tively), an observation supported by strong Genepaint in
situ hybridization signals at E14.5 in the ventricular zone
for both genes. Because postnatal expression of Etv1 and
Otx1 is specific to cortical layer V-VI, this result suggests
temporally differential (i.e., developmentally early and late)
requirements for these TFs during cortical development. In
contrast to the “Dorsal Telencephalon Network” we identi-
fied the layer II-IV marker Satb2 within our ≥ 3 fold up-
regulated data set (12 fold), an observation confirmed by
Genepaint-derived in situ hybridization. Consistent with
the dorsal telencephalic identity of the Eomes + population,
none of the nine genes associated with the “Ventral Telen-
cephalon Network” [4] were observed in the ≥ 3 fold up-
regulated population. By comparison to published studies
of excitatory neuron differentiation [2-4,57], this TF expres-
sion analysis developmentally positions the “maturation
spectrum” of the isolated E14.5 GFP + neurons to a period
after the expression of early dorsal specification genes (e.g.,
Pax6), coincident with neural specification genes (e.g., Neu-
rog1, Neurog2), and prior to the expression of late layer-
specific markers (e.g., Etv1 and Otx1).We hypothesized that the highly expressed “middle” and
“deep” group TFs are critical molecular regulators, per-
haps functioning to simultaneously repress precursor-
specific TFs and promote the expression of TFs
required for proper differentiation of cortical excitatory
neurons. To test this idea, a network analysis tool (IPA;
see Methods) was used to explore within our dataset pos-
sible regulatory interactions among the dynamically
expressed TFs (Figure 5). All TFs from the ≥ 3 fold up-
and down-regulated populations were imported into the
pathway analysis and the network of direct and indirect
interactions was identified. All interacting genes that were
identified, but absent from the populations of ≥ 3 fold up-
and down-regulated TFs, were assigned to a group
denoted “IPA Interacting Genes.”
Approximately 430 connections were identified for TFs
in the up- and down-regulated groups.
Only 4 direct interactions were reported between the
“deep group” or “middle group” genes and either the “upper
group” genes or the down-regulated genes (Figure 5). Nu-
merous direct interactions, however (50 of 54), were
detected that connected “middle” and “deep” genes to the
“IPA Interacting Genes” group. Included in this group are
signaling molecules that function non-cell autonomously in
neuronal development: Notch signaling [58], Wnt-βcatenin
signaling [59], VEGF [60], TGF β [37] and retinoic acid sig-
naling [61]. Each of these signaling pathways has been
shown to regulate either the production and/or differenti-
ation of excitatory cortical neurons. Surprisingly, only 14, or
~3%, of all detected interactions were direct between any
group of dynamically regulated TF genes (i.e., between the
4 lower boxes in Figure 5). The results of this network
analysis support models of neurogenesis that predict com-
plex interactions between specific cell autonomous (e.g.
VZIZCP+MZ
10522712 D 0.3 Rest RE1-silencing transcription factor (Rest), mRNA 
10450519 D 0.3 Tcf19 transcription factor 19 (Tcf19), mRNA. 
10478355 D 0.3 Mybl2 myeloblastosis oncogene-like 2 (Mybl2), mRNA.
10437687 D 0.2 Litaf LPS-induced TN factor (Litaf), mRNA 
10359624 D 0.2 Prrx1 paired related homeobox 1 (Prrx1), GRADIENT transcript variant 2, mRNA. 
10498284 D 0.2 Wwtr1 WW domain containing transcription regulator 1 (Wwtr1), mRNA. 
10510172 D 0.3 Hmgb2 high mobility group box 2 (Hmgb2), mRNA. 
10415396 D 0.3 Nfatc4 nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 (Nfatc4)
10594404 D 0.2 Smad3 MAD homolog 3 (Drosophila) (Smad3), mRNA 
10421950 D 0.3 Dach1 dachshund 1 (Drosophila) (Dach1), transcript variant 1, mRNA. 
10514466 D 0.2 Jun Jun oncogene (Jun), mRNA. 
10382328 D 0.1 Sox9 SRY-box containing gene 9 (Sox9), mRNA 
10474312 D 0.1 Pax6 paired box gene 6 (Pax6), mRNA.  PAX6
10424213 D 0.3 Zhx2 zinc fingers and homeoboxes protein 2 (Zhx2), mRNA. 
10515090 D 0.2 Cdkn2c cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) (Cdkn2c), mRNA. 
10464084 D 0.3 Tcf7l2 transcription factor 7-like 2, T-cell specific, HMG-box (Tcf7l2), mRNA. 
10391461 D 0.2 Brca1 breast cancer 1 (Brca1), mRNA. 
10403727 D 0.1 Gli3 GLI-Kruppel family member GLI3 (Gli3), mRNA. 
10385325 D 0.2 Pttg1 pituitary tumor-transforming 1 (Pttg1), mRNA 
10500630 D 0.3 Ttf2 transcription termination factor, RNA polymerase II (Ttf2), mRNA 
10469936 D 0.2 Nrarp Notch-regulated ankyrin repeat protein (Nrarp), mRNA. 
10395457 D 0.2 Etv1 ets variant gene 1 (Etv1), mRNA. 
10361771 D 0.3 Plagl1 pleiomorphic adenoma gene-like 1, mRNA (cDNA clone IMAGE:6856210). 
10491477 D 0.1 Sox2 SRY-box containing gene 2 (Sox2), mRNA. 
10366266 D 0.2 Pawr PRKC, apoptosis, WT1, regulator (Pawr), mRNA. 
10545458 D 0.1 Tcf3 transcription factor 3 (Tcf3), transcript variant 1, mRNA. 
10404975 D 0.1 Id4 inhibitor of DNA binding 4 (Id4), mRNA. 
10428534 D 0.2 Trps1 4 days neonate male adipose cDNA,clone:B430110C06 product:hypothetical protein
10580510 D 0.1 Sall1 sal-like 1 (Drosophila) (Sall1), mRNA. 
10452633 D 0.3 Tgif1 TG interacting factor 1 (Tgif1), mRNA. 
10363901 D 0.1 Etv5  cdna:Genscan chromosome:NCBIM37:10:71167116:71168033:1 
10527801 D 0.3 Brca2 breast cancer 2 (Brca2), transcript variant 1, mRNA. 
10499366 D 0.3 Pmf1 polyamine-modulated factor 1 (Pmf1), mRNA. 
10422272 D 0.2 Sox21 SRY-box containing gene 21 (Sox21), mRNA; SRY-box containing gene 21 (Sox21)
10600755 D 0.2 Arx aristaless related homeobox gene GRADIENT (Drosophila) (Arx), mRNA. 
10550593 D 0.3 Six5 sine oculis-related homeobox 5 homolog (Drosophila) (Six5), mRNA. 
10543058 D 0.1 Dlx5 distal-less homeobox 5 (Dlx5), transcript variant 1, mRNA. 
10373680 D 4.1 Neurod4 neurogenic differentiation 4 (Neurod4), mRNA. 
10479698 M 3.1 Myt1 myelin transcription factor 1 (Myt1), mRNA. 
10395074 M 6.9 Myt1l myelin transcription factor 1-like (Myt1l), transcript variant 1, mRNA. 
10360202 M 11.6 Nhlh1 nescient helix loop helix 1 (Nhlh1), mRNA. 
10358272 M 3.4 Lhx9 LIM homeobox protein 9 (Lhx9), transcript variant 3, mRNA. 
10390618 M 7.3 Neurod2 neurogenic differentiation 2 (Neurod2), mRNA. 
10484276 M 30.9 Neurod1 neurogenic differentiation 1 (Neurod1), mRNA. 
10503259 M 3.8 Trp53inp1 transformation related protein 53 inducible nuclear protein 1 (Trp53inp1) 
10544936 M 71.5 Neurod6 neurogenic differentiation 6 (Neurod6), mRNA. 
10354111 M 5.6 Aff3  AF4/FMR2 family, member 3, mRNA 
10352092 U 3.8 Zfp238 zinc finger protein 238 (Zfp238), transcript variant 1, mRNA. 
10545045 D U 3.5 D430015B01 RIKEN cDNA D430015B01 gene (D430015B01Rik), mRNA. 
10454235 U 3.3 Asxl3 gene:ENSMUSG00000045215 
10402554 U 4.5 Bcl11b B-cell leukemia/lymphoma 11B (Bcl11b), transcript variant 1, mRNA. 
10361807 U 17.8 Hivep2 human immunodeficiency virus type I enhancer binding protein 2 (Hivep2) 
10504838 U 12.0 Nr4a3 nuclear receptor subfamily 4, group A, member 3 (Nr4a3), mRNA 
10344679 U 3.9 St18 suppression of tumorigenicity 18 (St18), mRNA. 
10606174 U 3.1 Nap1l2 nucleosome assembly protein 1-like 2 (Nap1l2), mRNA. 
10423902 U 3.1 Zfpm2 zinc finger protein, multitype 2 (Zfpm2), mRNA. 
10406434 U 3.1 Mef2c myocyte enhancer factor 2C (Mef2c), mRNA. 
10529875 U 4.8 Ldb2 LIM domain binding 2 (Ldb2), transcript variant 2, mRNA. 
10429944 U 3.8 Scrt1 scratch homolog 1, zinc finger protein (Drosophila) (Scrt1), mRNA. 
10399691 U 4.1 Id2 inhibitor of DNA binding 2 (Id2), mRNA 
10490950 U 19.3 Bhlhb5 basic helix-loop-helix domain containing, class B5 (Bhlhb5), mRNA 
10472313 U 43.1 Tbr1  T-box brain gene 1 (Tbr1), mRNA. 
10354777 U 11.6 Satb2 special AT-rich sequence binding protein 2 (Satb2), mRNA. 
10549200 U 5.2 Sox5 SRY-box containing gene 5 (Sox5), mRNA. 
10381006 U 3.4 Thra thyroid hormone receptor alpha (Thra), mRNA. 
10469906 U 3.1 Nelf nasal embryonic LHRH factor (Nelf), transcript variant 1, mRNA. 
10478145 U 4.0 Ppp1r16b protein phosphatase 1, regulatory (inhibitor) subunit 16B (Ppp1r16b) 
10365428 U 3.3 Btbd11 BTB (POZ) domain containing 11 (Btbd11), transcript variant 1, mRNA. 
10523483 U 12.8 Prdm8 PR domain containing 8 (Prdm8) Transcription factor, mRNA. 
10538275 U 5.7 Nfe2l3 nuclear factor, erythroid derived 2, like 3 (Nfe2l3), mRNA. 
10358978 U 3.6 Ier5 immediate early response 5 (Ier5), mRNA. 
10365344 U 4.1 Tcp11l2 t-complex 11 (mouse) like 2 (Tcp11l2), mRNA. 
10438738 D U 3.9 Bcl6 B-cell leukemia/lymphoma 6 (Bcl6), mRNA. 

















Figure 4 Transcripts encoding transcription factors. Functional groupings of QISPs based upon Gene Ontology (GO) molecular function and
biological process annotations. a, Clustered QISPs of transcripts expressed≥ 3 fold higher in Eomes + neurons compared to GFP- cells. The left-
most dendrogram reveals the hierarchical arrangement of QISPs. b, Clustered QISPs of transcripts expressed≥ 3 fold lower in Eomes + neurons
compared to GFP- cells. a’ and b’.





























1 BCL6 / SMAD3 Bcl6 binds Smad3 and decreases Smad3 and p300 binding 1
2 BCL6 / JUN Bcl6 binds Jun 1
3 NEUROD1 / PAX6 Neurod1 increase Pax6 mRNA expression in duct cells 1
4 LHX9 / LDB2 Lhx9 binds Ldb2 1
5 SOX2 / ID2 Sox2 protein decrease Id2 mRNA expression 1
6 SMAD3 / ID2 Id2 binds Smad3 1
7 ID2 / WWTR1 Suppression of WWTR1 by siRNA decreases Tgfb1-dependent Id2 expression 1
8 ID2 / JUN Jun protein is i nvolved in the expression of Id2 mRNA 1
9 SOX2 / MEF2C Sox2, Klf4 and Oct4 protein increase Mef2c mRNA expression 1
10 MEF2C / DACH1 Dach1 decreases Tgfb-dependent Mef2c mRNA expression 1
11 MEF2C / JUN Acti vation of Mef2c protein increases t ransacti vation of Jun gene promoter 1
12 SOX9 / S OX5 Sox9 protein increases S ox5 mRNA expression in mouse limb bud 1
13 ZFPM2 / S OX 9 ZFPM2 deficiency decreases S ox9 mRNA in mouse gonad 1
14 THRA / JUN Thra protein increases Jun protein expression in dermal fibroblasts 1
Interact. # Genes Relationship Ref.
Figure 5 Network analyses of dynamically regulated transcription factors (TFs) in differentiating cortical excitatory neurons, derived
from the IPA-Ingenuity Network Tool (see Methods). a, ≥ 3 fold up- and ≥ 3 fold down-regulated TFs were imported along with
endogenous chemicals (e.g., retinoic acid) to populate the network. Grey boxes collect the up-regulated genes expressed in the “upper,” “mid”
and “deep” cortical regions (CP +MZ, IZ, VZ alone) as well as the down-regulated genes (VZ) and the group of IPA Interacting Genes. Gray lines
that are numbered indicate interactions between cortical zones (upper, middle, and deep); light blue lines indicate direct interactions of upper,
middle, and deep up-regulated genes, and down-regulated genes, with IPA interacting genes. Dark blue lines indicate interactions between IPA
interacting genes (see Results). b, Tabular summary of interactions between cortical zones. 1, Interaction identified by IPA Ingenuity analysis.
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http://www.biomedcentral.com/1471-2202/13/90transcription regulatory networks) and non-cell autono-
mous signaling mechanisms (e.g., Notch, TGFβ signaling)
during the maturation of cortical excitatory neurons.
Analysis of highly up- and down-regulated receptor genes
To more fully explore the role(s) of dynamically regu-
lated receptors in the differentiation and migration of
cortical neurons, we identified within the ≥ 3 fold up-
and down-regulated gene populations those with the
Gene Ontology descriptor “receptor activity,” and clus-
tered their respective QISPs (Figure 6). The down-
regulated receptors were enriched for signaling systems
with established functions in neuronal precursors
(Figure 6b, 6b’), including the Wnt-βcatenin signaling
family members Sfrp2, Fzd8, Lrp4, and Wnt7a. Wnt-
βcatenin signaling controls the production of neurons by
neural precursors [62] and regulates intermediate pre-
cursor proliferation [59,63]. The FGF receptors Fgfr2
and Fgfr3, and Notch family members Notchr1, Notchr2
and Notchr3 were also down-regulated. Notch receptors
have multiple roles in neurogenesis and differentiation,
including the regulation of neuronal precursor differenti-
ation [58,64], the promotion of glial fate [65], and den-
dritic growth [66,67]. Fgfr2 is required for excitatory
neuron development [68], with Fgfr3 required for attain-
ment of normal cortical and hippocampal volume and
caudal cortex development [69]. These results suggest that,
along with a dynamic enhancement of pro-differentiation
genes, genes responsible for the maintenance of precursor/
progenitor/glial phenotypes are dynamically suppressed at
E14.5 in the lineage of excitatory cortical neurons upon
exiting the VZ.
Thirty four receptors were identified in the ≥ 3 fold up
category (Figure 6a, 6a’). The top category of up-regulated
receptors includes those with established roles in axono-
genesis (8.14E-11 p-value): members of the Semaphorin
signaling family (Nrp1, Sema6d, Plxna2, Sema7a, Plxna4,
Sema4g, Plxnd1); Netrin receptors (Unc5d, Dcc); the Slit
signaling receptor Robo1. Because they are observed in
clusters 9 and 10 (Figure 3), many of these canonical che-
motropic signaling receptors are co-expressed in the IZ.
Specifically, Semaphorin signaling molecules are expressed
by excitatory neurons in the IZ soon after exit from the
VZ, with Netrin receptors and Robo1 expressed in more
superficial domains. These chemotropic signaling systems
have multiple roles and may be enabled for axonal growth
[70-72], neuronal migration [73], dendritic growth [74-76]
and cell survival [77].
Also included among the most highly up-regulated
receptors were eight GTP-binding protein-coupled
receptors (Gprs) (2.87 E-5 p-value), including Mcr4
(melanocortin receptor 4), Cnr1 (cannabinoid recep-
tor1), Sstr2 (somatostatin receptor 2), Gipr (gastric in-
hibitory polypeptide receptor), and the muscarinicacetylcholine receptor Chrm3. Cnr1 has multiple devel-
opmental roles including axonal guidance [78]. Specific
developmental functions of Mcr4, Gipr, and Chrm3 are
unknown, although Mcr4 interacts with Cnr1 to regulate
food intake in adults [79], Gipr regulates insulin secre-
tion after feeding [80], and Chrm3 is required for pan-
creatic insulin and glucagon release [81] and neuronal
endocannabinoid release [82]. The up-regulated Gprs
also include the orphan receptor Gpr21, as well as a
highly conserved receptor, Gpr85 (also known as Sreb2),
known to control brain size [83]. The Flamingo homolog
Celsr3, which is required for neuronal projections to the
anterior commissure as well as subcerebral targets, is
also up-regulated [84].
Analysis of highly up- and down-regulated neurotransmitter
receptors and synaptic genes
Neurotransmitters and their receptors have important
functions in the developing nervous system [85]. Al-
though our dataset contained no neurotransmitter
receptors down-regulated ≥ 3 fold, the up-regulated cat-
egory contained a variety of neurotransmitter receptor
subunits. Cholinergic receptor subunit β2 (Chrnb2) and
Chrna7 are up-regulated in the IZ and CP by 4.5 fold
and 2.8 fold, respectively. These receptor subunits form
heteromeric receptor complexes in the developing
brain, suggesting an early role for cholinergic signaling
as excitatory neurons migrate out of the VZ. Although
deletion of Chrna7 in mice does not cause overt struc-
tural abnormalities [86], recent studies indicate that
haploinsufficiency in CHRNA7 may cause a range of neu-
rodevelopmental phenotypes associated with the 15q13.3
syndrome, including developmental delay, mental retard-
ation and seizure [87]. Although no glutamate receptors
were upregulated ≥ 3 fold, N-methyl-D-aspartate (NMDA)
receptor subunits Grina and Grin1 were mildly up-
regulated (2.6 fold and 2.0 fold, respectively; data not
shown). In addition to mediating adult forms of synaptic
plasticity, NMDA receptors may mediate forms of spon-
taneous activity in the developing cortex [88] as well as
structural plasticity in the late embryonic and early post-
natal period [89,90]. mRNA encoding GABA (gamma-
amino-butyric-acid) receptor subunits were also up-regu-
lated, including Gabarg2 (4.6 fold) and Gabbrb2 (3.9 fold).
Gabarb3 was upregulated 2.8 fold. Deficiency in Gabarg2
may be causal in Dravet syndrome, a form of childhood
epilepsy [91]. GABA functions as an excitatory neuro-
transmitter in early development, xand deficiency in
GABAA receptor subunits alter Inhibitory Post Synaptic
Potentials (IPSPs) but not synapse number [92]. During
early periods GABA can function as a depolarizing
neurotransmitter and may relieve Mg2+ blockade of
NMDA receptors [93,94]. One glycine receptor subunit,
Glra2 (10.7 fold up-regulated) was identified in this
VZIZCP+MZa
b
10407173 D 0.33 Il6st interleukin 6 signal transducer (Il6st), mRNA. 
10492798 D 0.14 Sfrp2 secreted frizzled-related protein 2 (Sfrp2), mRNA
10526566 D 0.25 Ephb4 Eph receptor B4 (Ephb4), mRNA
10521111 D 0.16 Fgfr3 fibroblast growth factor receptor 3 (Fgfr3), mRNA. 
10453738 D 0.11 Fzd8 frizzled homolog 8 (Drosophila) (Fzd8), mRNA
10500666 D 0.11 Ptgfrn prostaglandin F2 receptor negative regulator (Ptgfrn), mRNA. 
10494595 D 0.09 Notch2 Notch gene homolog 2 (Drosophila) (Notch2), mRNA. 
10473880 D 0.15 Lrp4 low density lipoprotein receptor-related protein 4 (Lrp4), mRNA
10512279 D 0.30 Cntfr ciliary neurotrophic factor receptor (Cntfr), mRNA
10513256 D 0.12 Edg2 (Lpar1) endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 (Edg2) 
10449775 D 0.21 Notch3 Notch gene homolog 3 (Drosophila) (Notch3), mRNA. 
10423520 D 0.25 Sema5a sema, transmembrane and short cytoplasmic domain, (semaphorin) 5A
10380896 D 0.32 Erbb2 v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, mRNA. 
10561104 D 0.20 Axl AXL receptor tyrosine kinase (Axl), mRNA. 
10381898 D 0.27 Mrc2 mannose receptor, C type 2 (Mrc2), mRNA. 
10473281 D 0.23 Itgav integrin alpha V (Itgav), mRNA. 
10516789 D 0.30 Ptpru protein tyrosine phosphatase, receptor type, U (Ptpru), transcript variant 2, mRNA. 
10546339 D 0.18 Wnt7a wingless-related MMTV integration site 7A (Wnt7a), mRNA. 
10481056 D 0.13 Notch1 Notch gene homolog 1 (Drosophila) (Notch1), mRNA
10422164 D 0.05 Ednrb endothelin receptor type B (Ednrb), mRNA. 
10439766 D 0.19 Pvrl3 poliovirus receptor-related 3 (Pvrl3), transcript variant beta, mRNA
10468452 D 0.24 Sorcs1 VPS10 domain receptor protein SORCS 1 (Sorcs1), mRNA. 
10568436 D 0.19 Fgfr2 fibroblast growth factor receptor 2 (Fgfr2), transcript variant 1
10382341 D U 9.7 Sstr2 somatostatin receptor 2 (Sstr2), transcript variant 1, mRNA.
10560443 D U 4.1 Gipr gastric inhibitory polypeptide receptor (Gipr), mRNA.
10576639 M 9.7 Nrp1 neuropilin 1 (Nrp1) semaphorin receptor, mRNA
10475544 M 4.0 Sema6d sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D
10585778 M 4.9 Sema7a sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A
10543802 M 13.5 Plxna4 plexin A4 (Plxna4), mRNA.
10577999 M 5.0 Unc5d unc-5 homolog D (C. elegans) (Unc5d), mRNA.
10440344 M 3.1 Robo2 roundabout homolog 2 (Drosophila) (Robo2), mRNA.
10352867 M 4.0 Plxna2 plexin A2 (Plxna2), mRNA.
10499643 M 4.5 Chrnb2 cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) (Chrnb2)
10470529 M 3.4 Olfm1 olfactomedin 1 (Olfm1), transcript variant 1, mRNA.
10589130 M 4.5 Celsr3 cadherin EGF LAG seven-pass G-type receptor 3 (Celsr3), mRNA.
10485840 D M U 4.1 Ryr3 ryanodine receptor 3 (Ryr3), mRNA.
10459512 U 14.4 Mc4r melanocortin 4 receptor (Mc4r), mRNA.
10547100 U 3.8 Plxnd1 plexin D1 (Plxnd1), mRNA.
10607792 U 10.7 Glra2 glycine receptor, alpha 2 subunit (Glra2), mRNA.
10436519 U 5.8 Robo1 roundabout homolog 1 (Drosophila) (Robo1), mRNA.
10463430 U 3.9 Sema4g sema, immunoglobulin, transmembrane and short cytoplasmic domain (semaphorin) 4G
10532542 U 5.7 Sez6l seizure related 6 homolog like (Sez6l), mRNA.
10436865 U 6.1 Ifngr2 interferon gamma receptor 2 (Ifngr2), mRNA.
10399892 U 3.1 Gpr22 G protein-coupled receptor 22 (Gpr22), mRNA
10596095 U 3.0 Ephb1 Eph receptor B1 (Ephb1), mRNA.
10542414 U 4.1 Ptpro protein tyrosine phosphatase, receptor type, O (Ptpro), mRNA.
10375261 U 3.9 Gabrb2 gamma-aminobutyric acid (GABA-A) receptor, subunit beta 2 (Gabrb2), mR
10385283 U 4.6 Gabrg2 gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 2 (Gabrg2), t
10407591 U 3.0 Chrm3 cholinergic receptor, muscarinic 3, cardiac (Chrm3), mRNA.
10543219 U 7.8 Gpr85 G protein-coupled receptor 85 (Gpr85)
10522530 U 11.2 Kit kit oncogene (Kit), mRNA.
10503902 U 10.6 Cnr1 cannabinoid receptor 1 (brain) (Cnr1), mRNA.
10557535 U 3.7 Sez6l2 seizure related 6 homolog like 2 (Sez6l2), mRNA.
10504375 U 4.2 Npr2 natriuretic peptide receptor 2 (Npr2), mRNA.
10459671 U 5.1 Dcc deleted in colorectal carcinoma (Dcc), mRNA.
10563487 U 7.1 Abcc8 ATP-binding cassette, sub-family C (CFTR/MRP), member 8 (Abcc8), mRNA.
















Figure 6 Transcripts encoding receptors. Functional groupings of QISPs based on Gene Ontology molecular function and biological process
annotations. Graphical representation as in Figure 4. Clustered QISPs of transcripts expressed (a) ≥ 3 fold higher and (b) ≥ 3 fold lower in Eomes::
GFP + cells compared to eGFP- cells.
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http://www.biomedcentral.com/1471-2202/13/90group, although mice lacking Glra2 display no overt ab-
normalities of cortical structure [95].
Synaptogenesis begins quite early in cortical develop-
ment, at ~ E15 in subplate neurons in the rodent tem-
poral cortex [96], and continues well into the postnatal
period [97]. At the developmental point of our analysis,
E14.5, few if any synapses are present in the developing
CP. Despite this ultrastructural feature, we detected
not only multiple mRNAs encoding neurotransmitter
receptors, but also message for 22 other synaptic genes
identified by the Gene Ontology descriptor “synapse”
or “synaptic” (Figure 7). Included in this group aresynaptotagmin IV (SytIV), a calcium sensing protein
involved in neurotransmitter release [98], and synaptic
vesicle glycoproteins Sv2a and Sv2b that may also be
involved in regulated secretion [99]. Additionally detected
were three members of the Leucine Rich Repeat Trans-
membrane family (Lrrtm1-3), which function as synap-
tic organizers [100]. These results admit the possibilities
that neurotransmitter receptors and synaptic mRNAs
expressed by these immature excitatory neurons either
(a) do not encode functional proteins, or (b) encode
proteins involved in non-canonical functions. In either
case, the results are consistent with important roles for
Cameron et al. BMC Neuroscience 2012, 13:90 Page 15 of 23
http://www.biomedcentral.com/1471-2202/13/90classical neurotransmitter signaling molecules in shap-
ing the developmental trajectory of differentiating exci-
tatory cortical neurons.
Analysis of highly up- and down-regulated voltage-
dependent channels
Early patterns of electrical activity and calcium transients
are known to shape the developing nervous system
[101-104]. For this reason we queried the grouping of
QISPs associated with known voltage-dependent channels
(Figure 8). One down-regulated, and ten up-regulated, tran-
scripts were identified and grouped. Of the up-regulated
transcripts, four encode subunits of voltage-dependent cal-
cium channels (Cacna1e, Cacna1h, Cacnb3, Cacna2d1),
four encode voltage-dependent potassium channels (Kcna1,
Kcnj3, Kcnq3, Kcna6), and two encode voltage-dependent
sodium channels (Scn3b, Scn2a1). Hierarchical clustering
of these transcripts’ in situ hybridization profiles revealed
peak expression within the upper-most ten sROIs, corre-
sponding to the IZ, CP and MZ. This expression pattern
is spatially consistent with the acquisition of voltage-
dependent ionic currents in multipolar and migrating neu-
rons [103]. Only one gene (Kcnj10), encoding the weakly
inwardly rectifying potassium channel subunit Kir4.1, was
down-regulated (3.3 fold), and this observation was consist-
ent with the corresponding in situ hybridization data. Al-
though robustly down-regulated at this developmental time
point by differentiating excitatory cortical neurons, we note
that deficiency in KCNJ10 produces seizures, sensorineural
deafness, ataxia, mental retardation, and electrolyte imbal-
ance (SeSAME syndrome) [105,106]. This analysis is con-





























Figure 7 Transcripts encoding synaptic proteins. Functional groupings
process annotations. Graphical representation as in Figure 4. Clustered QISP
compared to GFP- cells. Note: there were no downregulated synaptic transtoward shaping the development of cortical neurons (and
presumably their synaptic/functional networks), but also
implicates specific channel types and sub-units in the mani-
festation of these early activity-dependent processes by cor-
tical excitatory neurons.
Analysis of highly up- and down-regulated adhesion
molecules
Spatial distributions of adhesion molecules, and changes
in such distributions, can in principal convey substantial
morphologic and migratory changes upon developing
neurons. To group expression patterns of known adhe-
sion molecules within the Eomes + neuronal lineage, we
sorted within the ≥ 3 fold up-regulated category for the
Gene Ontology descriptor “adhesion” (Figure 9). Twenty
one genes were identified that were verified by screening
the Genepaint database. These genes include several Im-
munoglobulin Super Family Members (IGSFMs), such as
L1cam, Dscam, Nfasc, Cadm3, Cntn1 and Cntn2. All of
these IGSFM genes have confirmed neurodevelopmental
functions: L1cam is involved in neuronal migration and
neurite outgrowth [107]; Dscam is a co-receptor for
Netrin signaling and is required for commissural axon
pathfinding [108]; Cadm3, also known as Nectin-like 1
or Syncam3, is a cell adhesion molecule involved in
axonal myelination [109]; Nfasc and Cntn1 interact to
promote the formation of paranodal axo-glial junctions
during axonal myelination [110]; Cntn2, also known as
Tag-1, is highly expressed on axons and can serve as a
substrate for interneuron migration [111] (although Tag-
1 knockout mice display no overt cortical phenotype
[112], there is a disruption of paranodal myelin junctions5.6 Cbln2 cerebellin 2 precursor protein, mRNA complete cds. 
3.2 Dlg2 discs, large homolog 2 (Drosophila) (Dlg2), mRNA. 
3.9 Syn2 synapsin II (Syn2), mRNA. 
6.7 Syt4 synaptotagmin IV (Syt4), mRNA. 
5.0 Snap25 synaptosomal-associated protein 25 (Snap25), mRNA. 
3.1 Syn1 synapsin I (Syn1), mRNA. 
3.5 Lrrtm1 leucine rich repeat transmembrane neuronal 1 (Lrrtm1) 
3.9 Cplx1 complexin 1 (Cplx1), mRNA. 
3.3 Svop SV2 related protein (Svop), mRNA. 
3.9 Gp1bb / Sept5 septin 5 (Sept5), mRNA. 
3.2 Erc2 ELKS/RAB6-interacting/CAST family member 2 (Erc2). 
3.9 Dmxl2 premature mRNA for mKIAA0856 protein. 
4.1 Lrrtm4 leucine rich repeat transmembrane neuronal 4, mRNA. 
4.3 Snca synuclein, alpha (Snca), transcript variant 1, mRNA. 
2.8 Lrrtm3 leucine rich repeat transmembrane neuronal 3 (Lrrtm3)
4.7 Lrrc7 leucine rich repeat containing 7 (Lrrc7), mRNA. 
6.1 Ank3 ankyrin 3, epithelial (Ank3), transcript variant 2, mRNA. 
3.7 Unc13a unc-13 homolog A (C. elegans) (Unc13a), mRNA. 
3.8 Trim9 tripartite motif protein 9 (Trim9), transcript variant 1, mRNA. 
5.0 Stxbp1 syntaxin binding protein 1 (Stxbp1), mRNA
6.5 Sv2b synaptic vesicle glycoprotein 2 b (Sv2b), transcript variant 2. 
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10462313 U 6.4 Slc1a1 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, Xag), member 1 (Slc1a1) 
10584549 U 3.9 Scn3b sodium channel, voltage-gated, type III, beta (Scn3b), transcript variant 2, mRNA. 
10358928 U 7.9 Cacna1e calcium channel, voltage-dependent, R type, alpha 1E subunit (Cacna1e), mRNA. 
10472400 U 5.3 Scn2a1 sodium channel, voltage-gated, type II, alpha 1 (Scn2a1), mRNA. 
10552857 U 12.0 Slc17a7 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 (Slc17a7),Vglut1
10429083 U 7.3 Kcnq3 potassium voltage-gated channel, subfamily Q, member 3 (Kcnq3), mRNA. 
10548051 U 4.0 Kcna6 potassium voltage-gated channel, shaker-related, subfamily, member 6 (Kcna6), mRNA 
10472155 U 4.8 Kcnj3 potassium inwardly-rectifying channel, subfamily J, member 3 (Kcnj3), mRNA 
10453233 U 5.0 Slc8a1 solute carrier family 8 (sodium/calcium exchanger), member 1 (Slc8a1), mRNA. 
10548047 U 4.1 Kcna1 potassium voltage-gated channel, shaker-related subfamily, member 1 (Kcna1), mRNA. 
10448925 D U 3.0 Cacna1h calcium channel, voltage-dependent, T type, alpha 1H subunit (Cacna1h), mRNA. 
10553501 M 19.4 Slc17a6 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 (Slc17a6), Vglut2 
10519815 U 6.5 Cacna2d1 calcium channel, voltage-dependent, alpha2/delta subunit 1 (Cacna2d1), mRNA. 
10426611 U 3.1 Cacnb3 calcium channel, voltage-dependent, beta 3 subunit (Cacnb3), transcript variant 1, mRNA. 
10511789 D U 3.3 Nkain3 Na+/K+ transporting ATPase interacting 3 (Nkain3), mRNA. 
10455873 D 0.33 Slc12a2 solute carrier family 12, member 2 (Slc12a2), mRNA. 
10543031 D 0.20 Slc25a13 solute carrier family 25 (mitochondrial carrier, adenine nucleotide translocator), member 13 (Slc25a13) 
10427590 D 0.13 Slc1a3 solute carrier family 1 (glial high affinity glutamate transporter), member 3 (Slc1a3)
10351781 D 0.30 Kcnj10 potassium inwardly-rectifying channel, subfamily J, member 10 (Kcnj10), mRNA. 
10550332 D 0.30 Slc1a5 solute carrier family 1 (neutral amino acid transporter), member 5 (Slc1a5), mRNA. 
















Figure 8 Transcripts encoding ion channels and solute carriers. Functional groupings of QISPs based on Gene Ontology molecular function
and biological process annotations. Graphical representation as in Figure 4. Clustered QISPs of transcripts expressed (a) ≥ 3 fold higher and (b) ≥ 3
fold lower in Eomes-GFP + cells compared to GFP- cells.
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http://www.biomedcentral.com/1471-2202/13/90[113]). Several Cadherins (Cadh8, Cadh11 and Cadh13)
as well as Protocadherin 20 were observed to be up-
regulated, although to date none of these Cadherin genes
have identified roles in cortical development. Surpris-
ingly, no members of the integrin family were observed
in the ≥ 3 fold, or the ≥ 2 fold, up-regulated groups, sug-












































Figure 9 Transcripts encoding adhesion molecules. Functional groupin
biological process annotations. Graphical representation as in Figure 4. Clus
lower in Eomes-GFP + cells compared to GFP- cells.dynamically regulated at the transcriptional level in the
Eomes + lineage at E14.5.
In contrast other adhesion molecules, such as Fibronectin
(Fn1), were down-regulated in the developing Eomes +
lineage. Two integrins that via heterodimerization form
a fibronectin receptor (and an activating integrin for
TGFβ signaling), Itgv and Itgβ8, were also down-9 Cdh8 cadherin 8 (Cdh8), transcript variant 1, mRNA. 
1 Opcml opioid binding protein/cell adhesion molecule-like (Opcml), mRNA. 
1 Pcdh20 protocadherin 20 (Pcdh20), mRNA. 
9 L1cam L1 cell adhesion molecule (L1cam), mRNA. 
3 Ctnna2 catenin (cadherin associated protein), alpha 2 (Ctnna2), transcript variant 2
3 Cdk5r1 cyclin-dependent kinase 5, regulatory subunit (p35) 1 (Cdk5r1), mRNA. 
1 9030425E11Rik RIKEN cDNA 9030425E11 gene (9030425E11Rik), mRNA. 
0 Flrt2 fibronectin leucine rich transmembrane protein 2 (Flrt2), mRNA 
Cntn2 contactin 2 (Cntn2)
8 Dscam Down syndrome cell adhesion molecule (Dscam), mRNA. 
2 Tes testis derived transcript (Tes), transcript variant 1, mRNA. 
0 Cadm3 cell adhesion molecule 3 (Cadm3), mRNA. 
1 Lrfn5 leucine rich repeat and fibronectin type III domain containing 5 (Lrfn5)
8 Aplp1 amyloid beta (A4) precursor-like protein 1 (Aplp1), mRNA. 
0 Nrxn1 neurexin I (Nrxn1), mRNA. 
8 Cdh11 cadherin 11 (Cdh11), mRNA. 
Cdh13 cadherin 13 (Cdh13), mRNA.
7 Nfasc neurofascin (Nfasc), mRNA. 
1 Clstn2 calsyntenin 2 (Clstn2), mRNA. 
7 Cdh12 cadherin 12 (Cdh12), mRNA. 
6 Flrt1 fibronectin leucine rich transmembrane protein 3 (Flrt1), mRNA 
Pvrl3 poliovirus receptor-related 3 (Pvrl3), transcript variant beta, mRNA 
Epdr1 ependymin related protein 1 (zebrafish) (Epdr1), mRNA 
Ctnna1 catenin (cadherin associated protein), alpha 1 (Ctnna1), mRNA. 
Ptpru protein tyrosine phosphatase, receptor type, U (Ptpru), transcript variant 2, mRNA. 
Fn1 fibronectin 1 (Fn1), mRNA. 
Mfge8 milk fat globule-EGF factor 8 protein (Mfge8), transcript variant 1, mRNA. 
Parva parvin, alpha (Parva), mRNA
Itgav integrin alpha V (Itgav), mRNA. 
Ttyh1 tweety homolog 1 (Drosophila) (Ttyh1), transcript variant 2, mRNA. 
Itgb8 integrin beta 8 (Itgb8), mRNA. 
Cdon cell adhesion molecule-related/down-regulated by oncogenes (Cdon), mRNA 
Boc biregional CAM-related/down-regulated by oncogenes (Cdon) binding protein (Boc)
Megf10 multiple EGF-like-domains 10 (Megf10), mRNA. 
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http://www.biomedcentral.com/1471-2202/13/90regulated. Conditional deletion of Itgαv in radial glia and
neurons causes cerebral hemorrhage [114] while reduced
expression of αvβ8 integrin is associated with arterior-
venous malformations [115]. Other down-regulated genes
encoding adhesion molecules were: Jam3, a tight-junction
protein essential for maintaining the integrity of the cere-
brovascular endothelium [116]; Cdh6, which is expressed
in the VZ where it may serve to assign the cortico-striatal
boundary [117]; two additional IGSFM genes, Boc and
Cdon, that are evident in the VZ, where they function
in Sonic Hedgehog signaling and are implicated in
forms of holoprosencephaly [118,119]. Taken together
these groupings suggest that expression (and suppressed
expression) of numerous adhesion molecules, particularly
specific members of the cadherin and IGSF families, are
required elements for migration, neurite formation, and
subsequent myelination of developing excitatory cortical
neurons.
Discussion
At E14.5 the cerebral neocortex is composed primarily
of neuronal precursors and immature neurons, with a
small number of differentiated preplate neurons. To bet-
ter identify specific patterns of gene expression within
the excitatory neuron lineage during early cortical devel-
opment, we combined FAC sorting and transcriptional
profiling with a new, comprehensive in situ hybridization
validation procedure, termed QISP. This approach
revealed 317 validated genes in the ≥ 3 fold up category
of transcripts. We then clustered the QISPs into groups
of spatially co-expressed genes that can contribute to the
combined processes of migration and differentiation.
This approach allowed us to identify 44 genes expressed
in the deep VZ that are likely to be IPC specific. These
deep genes would be difficult to isolate by a microdissec-
tion based profiling and in situ approach [13-15] because
of the mixture of cell types and maturity. Similarly, we
identified a group of 49 genes that are expressed in the
IZ and may contribute to the recently identified multi-
polar neuron stage cortical development [1], as well
identifying 224 genes expressed in the developing cor-
tical plate that in part contribute to the early morpho-
logic differentiation of cortical excitatory neurons
(Figure 10). This approach allows inferences about the
temporal sequence of neuronal development: While the
in situ analysis was performed at one time point (E14.5)
and is formally interpreted as a spatial pattern of gene
expression at that time point, an approximate develop-
mental timeline of gene expression within the lineage
can be inferred, based on the well-established observa-
tion that more superficial neurons in the developing
mammalian cortex are more mature [33,120]. This infer-
ence is particularly valid at early developmental time
points, such as E14.5, when the CP is starting to formand few neurons have “settled” or been displaced to dee-
per positions by subsequent, later-born neurons.
One of the initially surprising features of the data set
is the large number of genes that exceeded our empirical
expression threshold (RMA 7.0). We found that 53% of
all unique mRNAs are expressed above this threshold.
Although initially surprising, this result is consistent
with prior studies of more mature cortical tissues [30,31]
that contain a mixture of fully differentiated neurons
with differing molecular properties. Although mRNA ex-
pression is not equivalent to protein expression, the fact
that newly-generated excitatory cortical neurons display
a complex transcriptome points to the potential plasti-
city of these cells from their earliest developmental ori-
gins. The broad spectrum of expressed receptors
indicates chemosensitivity to major chemotropic signal-
ing mechanisms (Semaphorin, Ephrin, Netrin, and Slit)
and classical neurotransmitters including GABA, Glu-
tamate, Acetylcholine and Glycine. Immature excitatory
neurons are therefore potentially broadly sensitive to en-
vironmental cues, and could harness these cues to guide,
and ultimately define, their early differentiation and mi-
gration across the cerebral wall. While the large number
of signaling pathways underscores the potential plasticity
and adaptability of immature neurons, this observation
also highlights their potential susceptibility to toxic in-
sult and drugs of abuse.
The Eomes::eGFP transgene causes GFP expression for
a defined interval (approximately 3 days) in the early
postmitotic life of excitatory neurons. Our analyses
showed that the gene expressed by neurons during this
~ 3 day period of postmitotic life, is similar regardless of
whether the GFP + cells were isolated from E13.5 or
E14.5 embryos (Figure 2a and 2a’). This presumably
reflects the shared initial developmental trajectory of
these early born neurons, regardless of birthdate. This
finding supports the observation of a core excitatory
neuron developmental program centered on the tran-
scription factors Pax6, Eomes and Tbr1 [57]. Thus, while
our analyses focused on the comparison of E14.5 GFP +
cells to GFP- precursors, we expect that many (but not
all) of the genes we identified as upregulated in the tran-
sition from precursor to immature deep layer neuron
will also be upregulated during the differentiation of
later born, upper layer cortical neurons.
The complex interplay between the developing neuron
and its environment was highlighted in our analysis of the
network of transcription factors (TFs) that drive excitatory
neuron differentiation. Although we were able to identify a
total of 74 dynamically regulated TFs in the excitatory
lineage, only 3% of the IPA literature-based interactions
connected these TFs between different spatial zones (i.e.,
“deep,” middle,” and “upper” cortical plate). The remaining

























































Classification Upper Mid Deep
n=224 n=49 n=44
1 Transcription 10.7 16.3 11.4
2 Adhesion 7.6 6.1 2.3
3 Phosphatases 3.1 2.0 2.3
4 Receptors 9.4 20.4 6.8
5 Ion channels / Solute carriers 5.4 2.0 4.5
6 Kinases and Adaptors 5.8 8.2 6.8
7 Extracellular 7.1 12.2 13.6
8 Small G-protein signaling 6.7 2.0 2.3
9 Synaptic 8.5 4.1 2.3
10 Cytoskeletal 7.6 2.0 0.0
11 Proteolysis 2.2 0.0 6.8
12 Other enzymes 8.0 8.2 18.2
13 Other 11.6 10.2 13.6


















































Figure 10 Schematic of excitatory neuron migration, differentiation, and patterns of gene expression. a, Illustration of radial migration,
and general morphological characteristics, of excitatory neurons. RGC, radial glial cell; IPC, intermediate precursor cell; MPN, multipolar neuron;
BPN, bipolar neuron; PMN, postmigratory neuron; VZ, ventricular zone; IZ, intermediate zone; CP, cortical plate; MZ, marginal zone. b, Pie charts
representing gene clusters 1-14 (see Figure 3) as a function of their relative contribution to the population of≥ 3 fold up-regulated genes as a
function of cortical location (upper, middle, deep). The accompanying table (bottom) indicates the Gene Ontology (GO) classification for each of
the gene clusters, and the percentage of genes within each GO classification in each zone (D, M, U). c, The individual, greatest up-regulated
genes in the Eomes lineage for each cortical zone.
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http://www.biomedcentral.com/1471-2202/13/90to a group of “IPA Interacting Genes,” a collection that
included a number of molecules involved in non-cell au-
tonomous signaling, such as Tgfβ, Vegf, and Wnt- βcatenin
signaling systems. While this analysis only reports known
interactions, and is therefore likely to under represent the
true number of functional TF-TF interactions, it is presum-
ably also likely to under represent indirect molecularinteractions. So instead of a network composed exclusively
of sequentially active (or activated) TFs, our data is consist-
ent with an emerging model of early cortical neuron differ-
entiation that predicts interaction between cell autonomous
and non-cell autonomous mechanisms [102,121-124]. This
model helps account for one of the paradoxical features of
neuronal development: the stochastic cell type composition
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http://www.biomedcentral.com/1471-2202/13/90of clonally related neurons observed in, for example, the
neural retina [125-127] and cortex [128,129]. In contrast to
the invariant lineages that would be expected from a strictly
deterministic developmental program, the variable mixture
of neuronal subtypes within each clone may indicate a
“noisy” deterministic program and/or a developmental pro-
gram that relies on non-cell autonomous cues (e.g., growth
factors or neurotransmitters) that may change in functional
abundance and/or localization during development.
Another important result emerging from recent work
is that specific members of TF families control restricted
sets of phenotypic attributes. For example, Neurog2
enacts a program of motility in migrating neurons in the
IZ through activation of the Rho family GTPase Rnd2
[130]. Later in development a second bHLH TF, Ascl1,
regulates the transition to locomotory migration on ra-
dial glial fibers via Rnd3 activation [131]. Additionally,
the subcortical projection patterns of cortical neurons
depends on the expression of Sox5 [11] and may involve
other TFs as well [7,132,133]. This stepwise control of
neuronal phenotype may enable the appropriate matur-
ation of neurons, independent of the size of the develop-
ing cerebral cortex or the time required for neurons to
migrate across the cerebral wall. During early cortico-
genesis, mouse layer 6 neurons can transition from cell
cycle exit to a postmigratory differentiating neuron in
~1.5 days [22,134], whereas layer 2/3 cortical neurons
require 4-5 days for this transition [135]. Nevertheless, a
similar, if not identical, TF program is thought to under-
lie the maturation of both classes of neurons [3,57].
Developing neurons’ interactions with external cues that
promote (or suppress) the expression of stage-specific
TFs would thus permit the coordinated transitions of
neuronal phenotype (e.g., multipolar neuron to bipolar
migrating neuron) in a manner independent of a cell-
intrinsic “timer” of differentiation.
In this regard the cluster of genes expressed in the IZ
may be important for coordinating the multipolar
neuron stage, an early stage of migration, and later axon
initiation. In clusters 9 and 10 we observed a significant
enrichment of the Gene Ontology categories Cellular
Movement Signaling (p = 4.59E-05) as well as Axonal
Guidance Signaling Molecules (p = 1.28E-07) and bHLH
TFs including Neurod6 (72 fold) and Neurod1 (31 fold).
Neurod6 in particular may have a role in regulating the
mitochondrial mass increase and cytoskeletal rearrange-
ments prior to axonal growth [136], while other bHLHs,
including Neurod1, promote the expression of genes
critical for cortical migration, including the microtubule
associated protein Dcx, the Cdk5 regulatory subunit
p35, and the small GTPase RhoA [137]. The multipolar
neuron phenotype could thus be explained, in part, by
cellular specification provided by Neurod1 and Neurod6,
two of the most highly upregulated TFs in our data set.Conclusion
In summary, this study provides a rigorously validated
list of transcripts expressed by immature excitatory neu-
rons that have been grouped by in situ expression pat-
tern. We identified the transcriptional complexity of
these cells, and highlighted the potential functionality of
these neurons with regards to the expression of specific
chemotropic receptors, neurotransmitter receptors, ion
channels, adhesion molecules, and synaptic proteins.
The established association of many of the validated
genes with human neurological disorders revealed new
molecular bases for understanding how specific genes,
and functional networks of such genes, control neuronal
development and contribute to pathology. Future chal-
lenges include relating identified TFs and TF networks
to specific developmental events, and identifying the ex-
ogenous cues that coordinate these events.
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